EW Stock-Based Compensation
Edwards Lifesciences · Stock-Based Compensation
EW Stock-Based Compensation
Latest reported$42.20Mperiod ending
EW Quarterly Stock-Based Comp ($0.00 → $42.20M)
Quarterly stock-based compensation
High-resolution chart · PNG
EW stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 42,200,000 | |
| 45,400,000 | |
| 39,200,000 | |
| 41,200,000 | |
| 37,500,000 | |
| 40,200,000 | |
| 50,800,000 | |
| 42,100,000 | |
| 43,900,000 | |
| 44,600,000 | |
| 30,500,000 | |
| 32,600,000 | |
| 37,400,000 | |
| 38,900,000 | |
| 27,900,000 | |
| 30,300,000 | |
| 36,200,000 | |
| 32,400,000 | |
| 24,200,000 | |
| 26,600,000 | |
| 30,300,000 | |
| 28,200,000 | |
| 20,900,000 | |
| 23,000,000 | |
| 24,800,000 | |
| 23,900,000 | |
| 18,400,000 | |
| 19,800,000 | |
| 22,300,000 | |
| 20,800,000 | |
| 16,000,000 | |
| 17,400,000 | |
| 19,200,000 | |
| 18,400,000 | |
| 15,300,000 | |
| 15,800,000 | |
| 15,300,000 | |
| 15,200,000 | |
| 13,900,000 | |
| 14,400,000 | |
| 14,300,000 | |
| 14,300,000 | |
| 12,900,000 | |
| 12,600,000 | |
| 10,800,000 | |
| 13,600,000 | |
| 12,200,000 | |
| 12,200,000 | |
| 11,900,000 | |
| 12,000,000 | |
| 11,500,000 | |
| 11,900,000 | |
| 12,800,000 | |
| 11,200,000 | |
| 10,800,000 | |
| 10,900,000 | |
| 11,200,000 | |
| 9,200,000 | |
| 9,000,000 | |
| 10,500,000 | |
| 7,800,000 | |
| 7,700,000 | |
| 6,900,000 | |
| 8,600,000 | |
| 6,300,000 | |
| 7,500,000 | |
| 7,800,000 | |
| 7,900,000 | |
| 5,700,000 | |
| 6,900,000 | |
| 28,700,000 | |
| 0 | |
| 6,200,000 | |
| 6,600,000 | |
| 27,700,000 | |
| 0 | |
| 0 | |
| 6,900,000 | |
| 26,600,000 | |
| 0 | |
| 0 | |
| 5,800,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |